CUA guideline: The workup of azoospermic males

Journal of the Canadian Urological Association

Volumn 4, Issue 3, 2010, Pages 163-167

  Jarvi, Keith ^a   Lo, Kirk ^b   Fischer, Anthony ^c   Grantmyre, John ^d   Zini, Armand ^e   Chow, Victor ^f   Mak, Victor ^g  

^a UNIVERSITY OF TORONTO   (Canada)

^b MOUNT SINAI HOSPITAL   (Canada)

^c MCMASTER UNIVERSITY   (Canada)

^d DALHOUSIE UNIVERSITY   (Canada)

^e MCGILL UNIVERSITY   (Canada)

^f UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^g Urologist   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77953709439     PISSN: 19116470     EISSN: 19116470     Source Type: Journal    
DOI: 10.5489/cuaj.10050     Document Type: Article

References (31)

1. Fogle RH, Steiner AZ, Marshall FE, et al. Etiology of azoospermia in a large nonreferral inner-city population. Fertil Steril 2006;86:197-199.
2. Jarow JP, Espeland MA, Lipshultz LI. Evaluation of the azoospermic patient. I Urol 1989;142:62-65.
3. Fedder J, Cruger D, Oestergaard B, et al. Etiology of azoospermia in 100 consecutive nonvasectomized men. Fertil Steril 2004;82:1463-1465.
4. Wang C, So SY, Wong KK, et al. Chronic sinopulmonary disease in Chinese patients with obstructive azoospermia. J Androl 1987;8:225-229.
5. Matsumiya K, Namiki M, Takahara S, et al. Clinical study of azoospermia. Int J Androl 1994;17:140-142.
6. Assisted Reproductive Technology Success Rates. US Department of Health and Human Services, eds. 2005.
7. Mak V, Jaivi KA. The genetics of male infertility. IUrol 1996;156:1245-1256; discussion 1256-7.
8. von Eckardstein S, Simoni M, Bergmann M, et al. Serum inhibin B in combination with serum follicles-timulating hormone (FSH) is a more sensitive marker than serum FSH alone for impaired spermatogenesis in men, but cannot predict the presence of sperm in testicular tissue samples. I Clin Endocrinol Metab 1999;84:2496-2501.
9. Chen DY, Wang JJ, Huang YF, et al. Relationship between lipocalin-type prostaglandin D synthase and alpha-glucosidase in azoospermia seminal plasma. Clin Chim Acta 2005;354:69-76.
10. Mitchell V, Brabant S, Koscinski I, et al. Proacrosin, an acrosomal marker for the detection of spermato-genie cells in ejaculates from azoospermic men [in French]. Gynecol Obstet Fertil 2004;32:779-784.
11. Bordallo MA, Guimaraes MM, Pessoa CH, et al. Decreased serum inhibin B/FSH ratio as a marker of Sertoli cell function in male survivors after chemotherapy in childhood and adolescence. I Pediatr Endocrinol Metab 2004;17:879-887.
12. Frydelund-Larsen L, Krausz C, Leffers H, et al. Inhibin B: a marker for the functional state of the seminiferous epithelium in patients with azoospermia factor C microdeletions. I Clin Endocrinol Metab 2002;87:5618-5624.
13. Hipler UC, Hochheim B, Knoll B, et al. Serum inhibin B as a marker for spermatogenesis, Arch Androl 2001;46:217-222.
14. Brugo-Olmedo S, De Vincentiis S, Calamera JC, et al. Seium inhibin B may be a reliable marker of the presence of testicular spermatozoa in patients with nonobstructive azoospermia. Fertil Steril 2001;76:1124-1129.
15. Zöpfgen A, Priem F, Sudhoff F, et al. Relationship between semen quality and the seminal plasma components carnitine, alpha-glucosidase, fructose, citrate and granulocyte elastase in infertile men compared with a normal population. Hum Reprod 2000; 15:840-845.
16. Foresta C, Bettella A, Petraglia F, et al. Inhibin B levels in azoospermic subjects with cytologically characterized testicular pathology. Clin Endocrinol (Oxf) 1999;50:695-701.
17. Foppiani L, Schlatt S, Simoni M, et al. Inhibin B is a more sensitive marker of spermatogenetic damage than FSH in the irradiated non-human primate model. I Endocrinol 1999; 162:393-400.
18. Diamandis EP, Arnett WP, Foussias G, et al. Seminal plasma biochemical markers and their association with semen analysis findings. Urology 1999;53:596-603.
19. Fujisawa M, Tanaka H, Tatsumi N, et al. Telomerase activity in the testis of infertile patients with selected causes. Hum Reprod 1998;13:1476-1479.
20. Kret B, Milad M, Jeyendran RS. New discriminatory level for glucosidase activity to diagnose epididymal obstruction or dysfunction, Arch Androl 1995;35:29-33.
21. Hu YA, Huang YF. A serum marker of spermatogenesis-inhibin B [in Chinese]. Zhonghua Nan Ke Xue 2002;8:57-60.
22. Schlegel PN. Causes of azoospermia and their management. Repnd Fertil Dev 2004;16:561-572.
23. Kim ED, Gilbaugh JH 3rd, Patel VR, et al. Testis biopsies frequently demonstrate sperm in men with azoospermia and significantly elevated follicle-stimulating hormone levels. J Urol 1997; 157:144-146.
24. Gil Salom M. Spermatic recovery techniques for intracytoplasmic spermatozoid injection (ICSI) in male infertility [in Spanish], Arch Esp Urol 2004;57:1035-1046.
25. Schiff JD, Palermo GD, Veeck LL, et al. Success of testicular sperm extraction [corrected] and intracytoplasmic sperm injection in men with Klinefelter syndrome. J Clin Endocrinol Metab 2005;90:6263-6267.
26. Raman JD, Schlegel PN. Testicular sperm extraction with intracytoplasmic sperm injection is successful for the treatment of nonobstructive azoospermia associated with cryptorchidism. J Urol 2003;170:1287-1290.
27. Chan PT, Palermo GD, Veeck LL, et al. Testicular sperm extraction combined with intracytoplasmic sperm injection in the treatment of men with persistent azoospermia postchemotherapy. Cancer 2001;92:1632-1637.
28. Schlegel PN. Testicular sperm extraction: microdissection improves sperm yield with minimal tissue excision. Hum Reprod 1999;14:131-135.
29. Schlegel PN, Palermo GD, Goldstein M, et al. Testicular sperm extraction with intracytoplasmic sperm injection for nonobstructive azoospermia. Urology 1997;49:435-440.
30. Colpi GM, Piediferro G, Nerva F, et al. Sperm retrieval for intra-cytoplasmic sperm injection in nonobstructive azoospermia. Minerva UrolNefrol 2005;57:99-107.
31. Schlegel PN, Kaufmann J. Role of varicocelectomy in men with nonobstructive azoospermia. Fertil Steril 2004;81:1585-1588.